Nathalie Clément
Senior Vice President, Vector Development, Siren Biotechnology
Nathalie Clément is listed as Senior Vice President, Vector Development, Siren Biotechnology. Nathalie is scheduled to speak at Advanced Therapies Week 2027 on 20 January 2027.
Compiled from published conference agendas; not yet confirmed by Nathalie. Is this you? Claim this profile.
About
Dr. Clément has 25+ years of experience in the field of Gene Therapy, with industry-leading expertise in adeno-associated virus (AAV) vector manufacturing. At the Powell Gene Therapy Center of the University of Florida, Gainesville, she led AAV process development and manufacturing for R&D POC, IND-enabling Toxicology and IND studies, oversaw manufacturing and release of 10+ AAV INDs. Her research focused on developing scalable GMP-ready platforms using the HSV and the transfection systems in suspension. Dr. Clément joined National Resilience in 2021, as the PD Director, Viral Vaccines and Gene Therapy, where she oversaw multiple industry-sponsored manufacturing programs. She joined Siren Biotechnology in January 2022, a clinical-stage company focused on delivering a cure for cancer, where she leads manufacturing and CMC operations.
Upcoming
Advanced Therapies Week 2027 19 January 2027 – 21 January 2027
- Session 6: Viral Vectors - Innovation in LVV: building the next generation of safe, scalable, and affordable vector platforms Speaker · 20 January 2027
- Panel discussion Speaker · 21 January 2027
- Session 9: Next-generation vector systems and emerging payloads – how and where can they enable the cell & gene therapy field to advance? Speaker · 21 January 2027
Spoke alongside
People who have shared a session with Nathalie at events on B2DB.
- Jeroen de Vrij CEO · ExoVectory 2 shared sessions
- Mercedes Segura Gally VP Process Development · Editas Medicine 2 shared sessions
- Boro Dropulić Executive Director, Caring Cross; CEO · Vector BioMed 1 shared session
- Sheena Smith Assistant Professor of Biotechnology, School of Chemistry, Chemical Engineering and Biotechnology (CCEB) · Nanyang Technological University, Singapore 1 shared session
- Sooraj Achar CSO · Akimbo Bio 1 shared session